Gestational Diabetes Mellitus. Diabetes mellitus arising in pregnancy
Conditions
Interventions
Intervention 1: Intervention group: Daily intake of 3 grams of oatmeal powder twice a day with breakfast and lunch meals, with a 7-6 hour interval between meals plus a glass of ordinary water(which is
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Having written consent to participate in research Reading and writing literacy Iranian and residing in Mashhad Have a phone number Singleton pregnancy The gestational age between 24 and 28 weeks based on the first day of the last menstruation or the first trimester ultrasound Disrupting the test result of diagnosis of gestational diabetes at 24-28 weeks of pregnancy(Fasting blood sugar equal to or greater than 92 mg/dl or 1 hour glucose after taking 75 g glucose equal to or greater than 180 mg/dl or 2 hours glucose after taking 75 g glucose equal to or greater than 153 mg/dl) Having fasting blood glucose less than 95 mg/dl and two hours after meals less than 120 mg/dl in an experiment to confirm the treatment of gestational diabetes mellitus with a diet (after an abnormality of one of the factors tested In order to diagnose gestational diabetes) Confirmation of treatment gestational diabetes mellitus by a Gynecologist
Exclusion criteria
Exclusion criteria: Addiction Opiate and smoking Having a medical illness Having obstetrics problems Under the supervision of a Psychiatrist in the last six months and taking psychiatric drugs Having overt Diabetes Mellitus Having allergy to Okra or plant products Malvacea family Sick with Bronchitis Having speech and behavioral disorders that prevent contact with the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose. Timepoint: Baseline, 2 weeks and 4 weeks after intervention. Method of measurement: Venous blood samples.;Blood glucose two hours after a meal. Timepoint: Baseline, 2 weeks and 4 weeks after intervention. Method of measurement: Venous blood samples. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahla Salarfard
Mashhad University of Medical Sciences
Outcome results
None listed